334 related articles for article (PubMed ID: 26521151)
1. Attenuation of functional hyperemia to visual stimulation in mild Alzheimer's disease and its sensitivity to cholinesterase inhibition.
Janik R; Thomason LA; Chaudhary S; Dorr A; Scouten A; Schwindt G; Masellis M; Stanisz GJ; Black SE; Stefanovic B
Biochim Biophys Acta; 2016 May; 1862(5):957-65. PubMed ID: 26521151
[TBL] [Abstract][Full Text] [Related]
2. Hemodynamic effects of cholinesterase inhibition in mild Alzheimer's disease.
Chaudhary S; Scouten A; Schwindt G; Janik R; Lee W; Sled JG; Black SE; Stefanovic B
J Magn Reson Imaging; 2013 Jul; 38(1):26-35. PubMed ID: 23239554
[TBL] [Abstract][Full Text] [Related]
3. Quantitative assessment of cerebral hemodynamic parameters by QUASAR arterial spin labeling in Alzheimer's disease and cognitively normal Elderly adults at 3-tesla.
Mak HK; Chan Q; Zhang Z; Petersen ET; Qiu D; Zhang L; Yau KK; Chu LW; Golay X
J Alzheimers Dis; 2012; 31(1):33-44. PubMed ID: 22504315
[TBL] [Abstract][Full Text] [Related]
4. Brain perfusion follow-up in Alzheimer's patients during treatment with acetylcholinesterase inhibitors.
Nobili F; Koulibaly M; Vitali P; Migneco O; Mariani G; Ebmeier K; Pupi A; Robert PH; Rodriguez G; Darcourt J
J Nucl Med; 2002 Aug; 43(8):983-90. PubMed ID: 12163621
[TBL] [Abstract][Full Text] [Related]
5. Vascular contributions to cognitive impairment, clinical Alzheimer's disease, and dementia in older persons.
Kapasi A; Schneider JA
Biochim Biophys Acta; 2016 May; 1862(5):878-86. PubMed ID: 26769363
[TBL] [Abstract][Full Text] [Related]
6. Lower cerebral blood flow is associated with faster cognitive decline in Alzheimer's disease.
Benedictus MR; Leeuwis AE; Binnewijzend MA; Kuijer JP; Scheltens P; Barkhof F; van der Flier WM; Prins ND
Eur Radiol; 2017 Mar; 27(3):1169-1175. PubMed ID: 27334014
[TBL] [Abstract][Full Text] [Related]
7. Impaired cerebral vasoreactivity to CO2 in Alzheimer's disease using BOLD fMRI.
Cantin S; Villien M; Moreaud O; Tropres I; Keignart S; Chipon E; Le Bas JF; Warnking J; Krainik A
Neuroimage; 2011 Sep; 58(2):579-87. PubMed ID: 21745581
[TBL] [Abstract][Full Text] [Related]
8. Discriminative Power of Arterial Spin Labeling Magnetic Resonance Imaging and 18F-Fluorodeoxyglucose Positron Emission Tomography Changes for Amyloid-β-Positive Subjects in the Alzheimer's Disease Continuum.
Tosun D; Schuff N; Jagust W; Weiner MW;
Neurodegener Dis; 2016; 16(1-2):87-94. PubMed ID: 26560336
[TBL] [Abstract][Full Text] [Related]
9. Application of calibrated fMRI in Alzheimer's disease.
Lajoie I; Nugent S; Debacker C; Dyson K; Tancredi FB; Badhwar A; Belleville S; Deschaintre Y; Bellec P; Doyon J; Bocti C; Gauthier S; Arnold D; Kergoat MJ; Chertkow H; Monchi O; Hoge RD
Neuroimage Clin; 2017; 15():348-358. PubMed ID: 28560160
[TBL] [Abstract][Full Text] [Related]
10. Neurovascular dysfunction and neurodegeneration in dementia and Alzheimer's disease.
Nelson AR; Sweeney MD; Sagare AP; Zlokovic BV
Biochim Biophys Acta; 2016 May; 1862(5):887-900. PubMed ID: 26705676
[TBL] [Abstract][Full Text] [Related]
11. Long-Term Response to Cholinesterase Inhibitor Treatment Is Related to Functional MRI Response in Alzheimer's Disease.
Miettinen PS; Jauhiainen AM; Tarkka IM; Pihlajamäki M; Gröhn H; Niskanen E; Hänninen T; Vanninen R; Soininen H
Dement Geriatr Cogn Disord; 2015; 40(5-6):243-55. PubMed ID: 26305064
[TBL] [Abstract][Full Text] [Related]
12. Vascular mTOR-dependent mechanisms linking the control of aging to Alzheimer's disease.
Galvan V; Hart MJ
Biochim Biophys Acta; 2016 May; 1862(5):992-1007. PubMed ID: 26639036
[TBL] [Abstract][Full Text] [Related]
13. Early-stage differentiation between presenile Alzheimer's disease and frontotemporal dementia using arterial spin labeling MRI.
Steketee RM; Bron EE; Meijboom R; Houston GC; Klein S; Mutsaerts HJ; Mendez Orellana CP; de Jong FJ; van Swieten JC; van der Lugt A; Smits M
Eur Radiol; 2016 Jan; 26(1):244-53. PubMed ID: 26024845
[TBL] [Abstract][Full Text] [Related]
14. Reduced blood oxygenation level dependent connectivity is related to hypoperfusion in Alzheimer's disease.
Göttler J; Preibisch C; Riederer I; Pasquini L; Alexopoulos P; Bohn KP; Yakushev I; Beller E; Kaczmarz S; Zimmer C; Grimmer T; Drzezga A; Sorg C
J Cereb Blood Flow Metab; 2019 Jul; 39(7):1314-1325. PubMed ID: 29431005
[TBL] [Abstract][Full Text] [Related]
15. Longitudinal Cerebral Blood Flow Changes in Normal Aging and the Alzheimer's Disease Continuum Identified by Arterial Spin Labeling MRI.
Camargo A; Wang Z;
J Alzheimers Dis; 2021; 81(4):1727-1735. PubMed ID: 33967053
[TBL] [Abstract][Full Text] [Related]
16. Brain perfusion in dementia with Lewy bodies and Alzheimer's disease: an arterial spin labeling MRI study on prodromal and mild dementia stages.
Roquet D; Sourty M; Botzung A; Armspach JP; Blanc F
Alzheimers Res Ther; 2016 Jul; 8():29. PubMed ID: 27401267
[TBL] [Abstract][Full Text] [Related]
17. Predictors of Response to Cholinesterase Inhibitors Treatment of Alzheimer's Disease: Date Mining from the TREDEM Registry.
Gallucci M; Spagnolo P; Aricò M; Grossi E
J Alzheimers Dis; 2016; 50(4):969-79. PubMed ID: 26836164
[TBL] [Abstract][Full Text] [Related]
18. Early- versus late-onset Alzheimer's disease in clinical practice: cognitive and global outcomes over 3 years.
Wattmo C; Wallin ÅK
Alzheimers Res Ther; 2017 Aug; 9(1):70. PubMed ID: 28859660
[TBL] [Abstract][Full Text] [Related]
19. Delayed rather than decreased BOLD response as a marker for early Alzheimer's disease.
Rombouts SA; Goekoop R; Stam CJ; Barkhof F; Scheltens P
Neuroimage; 2005 Jul; 26(4):1078-85. PubMed ID: 15961047
[TBL] [Abstract][Full Text] [Related]
20. Neurovascular unit impairment in early Alzheimer's disease measured with magnetic resonance imaging.
van de Haar HJ; Jansen JFA; van Osch MJP; van Buchem MA; Muller M; Wong SM; Hofman PAM; Burgmans S; Verhey FRJ; Backes WH
Neurobiol Aging; 2016 Sep; 45():190-196. PubMed ID: 27459939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
